Literature DB >> 1491126

Cervical pheochromocytoma: a rare localization and a difficult diagnosis.

G Becker1, F Jockenhövel, R Bauer, S Lederbogen, R Lange, D Reinwein.   

Abstract

A 45-year-old hypertensive female with insulin-treated diabetes mellitus presented to our clinic with elevated urinary norepinephrine (NE) concentrations and a negative 131-metaiodobenzylguanidine (MIBG) scintigraphy, errouneously limited to the abdomen, for evaluation of a pheochromocytoma (Pheo). Despite antihypertensive medications blood pressure remained highly variable and frequently elevated. Further biochemical testing, including a glucagon provocation test and a clonidine-suppression test, revealed autonomous NE secretion. In order to avoid repeat MIBG-scintigraphy, other non invasive imaging techniques were performed, including real time sonography (7.5 MHz) of the neck which revealed a tumor. Fine needle aspiration of this tumor tissue demonstrated cells compatible with Pheo. Histology and immunohistochemistry of the excised tumor confirmed the diagnosis of Pheo. After surgical removal of the tumor, urinary and plasma NE levels normalized. Without any medication the blood pressure of the patient was now only slightly hypertensive. Only half of the daily insulin dose was needed to maintain the patient euglycemic.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1491126     DOI: 10.1007/bf03347649

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  12 in total

1.  Recurrent pheochromocytoma; report of a case in a previously treated child.

Authors:  T E CONE
Journal:  Pediatrics       Date:  1958-06       Impact factor: 7.124

Review 2.  Pheochromocytoma.

Authors:  N L Benowitz
Journal:  Adv Intern Med       Date:  1990

Review 3.  Diagnostic evaluation of pheochromocytoma.

Authors:  S G Sheps; N S Jiang; G G Klee
Journal:  Endocrinol Metab Clin North Am       Date:  1988-06       Impact factor: 4.741

Review 4.  [Diagnosis of pheochromocytoma].

Authors:  M Stimpel; G Wambach
Journal:  Dtsch Med Wochenschr       Date:  1987-09-11       Impact factor: 0.628

5.  Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979.

Authors:  C M Beard; S G Sheps; L T Kurland; J A Carney; J T Lie
Journal:  Mayo Clin Proc       Date:  1983-12       Impact factor: 7.616

6.  Clonidine-suppression test: a useful aid in the diagnosis of pheochromocytoma.

Authors:  E L Bravo; R C Tarazi; F M Fouad; D G Vidt; R W Gifford
Journal:  N Engl J Med       Date:  1981-09-10       Impact factor: 91.245

7.  [A single, rapid, selective and quantitative determination of adrenaline and noradrenaline in the plasma by a combination of solvent extraction, HPLC separation and electrochemical detection].

Authors:  H J Bauch; U Kelsch; W H Hauss
Journal:  J Clin Chem Clin Biochem       Date:  1986-09

8.  Clonidine suppression test for pheochromocytoma: examples of misleading results.

Authors:  H C Taylor; D Mayes; A H Anton
Journal:  J Clin Endocrinol Metab       Date:  1986-07       Impact factor: 5.958

9.  Measurement of norepinephrine and 3,4-dihydroxyphenylglycol in urine and plasma for the diagnosis of pheochromocytoma.

Authors:  M W Duncan; P Compton; L Lazarus; G A Smythe
Journal:  N Engl J Med       Date:  1988-07-21       Impact factor: 91.245

10.  Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series.

Authors:  M G Sutton; S G Sheps; J T Lie
Journal:  Mayo Clin Proc       Date:  1981-06       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.